Apple | Mobile |
---|---|
Business Dev & Design Entertainment | Social Media Tech Web Video |
Apple | Mobile |
---|---|
Business Dev & Design Entertainment | Social Media Tech Web Video |
Develops and commercializes pharmaceutical products.
Year Established: | |
Funding: | |
Address: | Madison, WI 53719 |
Telephone: | 2147483647 |
Mobile: | |
Fax: | (608) 277-8041 |
Mail: | |
Company URL: | http://www.procertus.com |
Company News
March, 2010 - Dr. Deepak Khuntia and Dr. James Cleary at the University of Wisconsin Carbone Cancer Center open patient enrollment in a Phase I/II clinical trial to determine the safety and efficacy in oral mucositis prevention of topically applied vasoconstrictor in patients receiving radiotherapy for head and neck cancer.
June, 2009 - Dr. James Cleary and Dr. Deepak Khuntia at the University of Wisconsin Carbone Cancer Center begin patient enrollment in a Phase I/II clinical trial to determine the safety and efficacy in radiodermatitis prevention of topically applied vasoconstrictor in patients receiving radiotherapy to treat bone metastases.
June 29, 2009 - Milwaukee Journal Sentinel does interview of acting CEO (Paul Weiss) about opened clinical trials and ProCertus product development.
June 30, 2009 - ProCertus BioPharm, Inc. closes $2.1 Million Series A Financing led by Novartis Venture Fund and Venture Investors, LLC.
June, 2009 - Series A investment round covered by Wisconsin State Journal, The Business Journal and other publications.
May, 2008 - Investigators (Dr. James Cleary et al.) at University of Wisconsin Carbone Cancer Center complete Phase I clinical study of DermX/ProDermaCel
Novartis Venture Fund (FKA: Novartis Corp.),Venture Investors LLC
Dr. William E. Fahl Founder, Chairman, and Chief Scientific Officer
Dr. Paul M. Weiss Acting President and CEO, Director
Dr. Allen L. Thunberg Vice President-Development
Todd G. Argall, C.P.A. Vice President-Finance
George Arida, M.B.A., Managing Director, Venture Investors, LLC Lead Director
Dr. Campbell Murray, Managing Director, Novartis Venture Fund Director
Robert Lippert, M.B.A., President and CEO, ZARS, Inc. Director
Joseph V. Gulfo, M.D., M.B.A., President and CEO, Electro-Optical Sciences, Inc. Director